63E vs PHAR: Side-by-Side Comparison
Compare ONWARD MEDICAL BV EO -12 (63E) and Pharming Group N.V. (PHAR) side by side: market cap EUR 174.52M vs USD 965.83M. Financials, growth and model signals on Bullrun.
| Metric | 63E | PHAR |
|---|---|---|
| Company | ONWARD MEDICAL BV EO -12 | Pharming Group N.V. |
| Country / Exchange | Netherlands · F | Netherlands · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 174.52M | USD 965.83M |
| P/E ratio | — | 79.9 |
| Dividend yield | — | — |
| Valuation model | — | 37.6% overvalued |
| Revenue (latest FY) | EUR 3.78M | — |
| Revenue growth YoY | +1550.7% | — |
| Net income | EUR -41.79M | — |
| Gross margin | 72.5% | — |
| Diluted EPS | -0.90 | — |